| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |